Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
作者信息
Teramoto Tamio, Sasaki Jun, Ishibashi Shun, Birou Sadatoshi, Daida Hiroyuki, Dohi Seitaro, Egusa Genshi, Hiro Takafumi, Hirobe Kazuhiko, Iida Mami, Kihara Shinji, Kinoshita Makoto, Maruyama Chizuko, Ohta Takao, Okamura Tomonori, Yamashita Shizuya, Yokode Masayuki, Yokote Koutaro
机构信息
Committee for Epidemiology and Clinical Management of Atherosclerosis.
出版信息
J Atheroscler Thromb. 2014;21(2):86-92. doi: 10.5551/jat.19158. Epub 2013 Dec 10.
PMID:24335038
Abstract
摘要
相似文献
1
Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
J Atheroscler Thromb. 2014;21(2):86-92. doi: 10.5551/jat.19158. Epub 2013 Dec 10.
2
Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
J Atheroscler Thromb. 2014;21(2):93-8. doi: 10.5551/jat.19349. Epub 2013 Dec 10.
3
Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
J Atheroscler Thromb. 2014;21(2):82-5. doi: 10.5551/jat.19141. Epub 2013 Dec 10.
4
Women. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version.
J Atheroscler Thromb. 2014;21(4):291-5. doi: 10.5551/jat.19711. Epub 2013 Dec 10.
5
Diagnosis of atherosclerosis. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version.
J Atheroscler Thromb. 2014;21(4):296-8. doi: 10.5551/jat.19737. Epub 2013 Dec 10.
6
Treatment A) lifestyle modification: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
J Atheroscler Thromb. 2013;20(12):835-49. doi: 10.5551/jat.18820. Epub 2013 Oct 29.
7
Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
J Atheroscler Thromb. 2013;20(12):850-60. doi: 10.5551/jat.19166. Epub 2013 Dec 10.
8
Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version.
J Atheroscler Thromb. 2013;20(6):517-23. doi: 10.5551/jat.15792. Epub 2013 May 11.
9
Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012.
J Atheroscler Thromb. 2013;20(7):603-15. doi: 10.5551/jat.15867. Epub 2013 Jul 25.
10
Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.
J Atheroscler Thromb. 2007 Apr;14(2):45-50. doi: 10.5551/jat.14.45.
引用本文的文献
1
Clinical significance of costimulatory molecules CD40/CD40L and CD134/CD134L in coronary heart disease: A case-control study.
Medicine (Baltimore). 2017 Aug;96(32):e7634. doi: 10.1097/MD.0000000000007634.
2
Validity of a Novel Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Diabetic Patients.
J Atheroscler Thromb. 2016 Dec 1;23(12):1355-1364. doi: 10.5551/jat.35972. Epub 2016 Sep 2.
3
Diagnostic Value of Serum YKL-40 Level for Coronary Artery Disease: A Meta-Analysis.
J Clin Lab Anal. 2016 Jan;30(1):23-31. doi: 10.1002/jcla.21804.
4
Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease.
J Atheroscler Thromb. 2016 Aug 1;23(8):908-21. doi: 10.5551/jat.32672. Epub 2016 Mar 5.
Zotero 插件